Tissue Regenix Completes Acquisition of CellRight Technologies

04:08 EDT 9 Aug 2017 | Businesswire
This article has expired, however you can still download the PDF.
Acquisition expands Tissue Regenix’s U.S. presence in regenerative medicine with addition of complementary bone platform and supports upcoming orthopaedics launch Tissue Regenix Group plc, a UK- based regenerative medical ...

Other Sources for this Article

Tissue Regenix Group
Caitlin Pearson
Corporate Communications Director
FTI Consulting
Mo Noonan
0203 727 1000


More From BioPortfolio on "Tissue Regenix Completes Acquisition of CellRight Technologies"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...

Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...